Higher Responsiveness for Women, High Transaminase Levels, and Fat Percentage to Pemafibrate Treatment for NAFLD

Aim: Pemafibrate (PEM) is a novel selective peroxisome proliferator-activated receptor alpha modulator that is effective for hypertriglyceridemia accompanying non-alcoholic fatty liver disease (HTG-NAFLD). This study aimed to identify the predictors of PEM efficacy for HTG-NAFLD in clinical practice...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwadare, Takanobu, Kimura, Takefumi, Kunimoto, Hideo, Tanaka, Naoki, Wakabayashi, Shun-ichi, Yamazaki, Tomoo, Okumura, Taiki, Kobayashi, Hiroyuki, Yamashita, Yuki, Sugiura, Ayumi, Joshita, Satoru, Umemura, Takeji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687993/
https://www.ncbi.nlm.nih.gov/pubmed/36359326
http://dx.doi.org/10.3390/biomedicines10112806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687993/
https://www.ncbi.nlm.nih.gov/pubmed/36359326
http://dx.doi.org/10.3390/biomedicines10112806

Ejemplares similares